Oncopath Genomics Inc is categorized under Medical Labs in Highland Park, NJ and active since 2011.
Oncopath Genomics Inc was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Emmanuel Zachariah at the company’s single location by writing to 406 Raritan Avenue Unit 4394, Highland Park, New Jersey NJ 08904 or by phoning (732) 485-5428. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Oncopath Genomics Inc |
| Contact Person: | Emmanuel Zachariah |
| Address: | 406 Raritan Avenue Unit 4394, Highland Park, New Jersey 08904 |
| Phone Number: | (732) 485-5428 |
| Website Address: | oncopathgenomics.com |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Oncopath Genomics Inc was started in 2011 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Emmanuel Zachariah for inquiries that concern Oncopath Genomics Inc by calling the company number (732) 485-5428, as your correspondence is most welcome. Additionally, the physical location of the single location of Oncopath Genomics Inc can be found at the coordinates 40.499694,-74.425908 as well as the street address 406 Raritan Avenue Unit 4394 in Highland Park, New Jersey 08904.
For its online presence, you may visit Oncopath Genomics Inc’s website at oncopathgenomics.com and engage with its social media outlets through on Twitter and on Facebook.